-
A Father Rises in Support of His Son
A Father Rises in Support of His Son: On this powerful episode of the “In
-
PPMD Applauds FDA Launch of Rare Disease Innovation Hub — A Milestone for Rare Disease Patients
Parent Project Muscular Dystrophy (PPMD) welcomes the recent announcement by the United States Food and
-
Fun summer activities that are still doable with Duchenne
I often read social media posts from moms asking for safe and fun ideas for
-
Losmapimod improved, stabilized FSHD upper limb function: Study
One year of losmapimod taken twice a day improved or stabilized upper limb function and
-
NHL All-Star Ryan Getzlaf Returns to the Links for the 13th Annual Getzlaf Golf Shootout on September 13-14, Benefiting CureDuchenne
Event Has Raised More Than $5.8 Million Over the Last 12 Years to Drive a
-
Ullrich Awareness Day
Finally, after years of battling and campainging, we now have an official Ullrich Muscular Dystrophy
-
Protected: FDA Approval of ELEVIDYS: Key Takeaways from the CureDuchenne Webinar
This content is password protected. To view it please enter your password below: Password: The
-
What I want people to know about FSHD and its progression
As I was finishing up a recent interview with the host of “FSHD Radio: Straight
-
Twins offer insights into DM1 cognitive deficit contributors
A pair of identical twins with myotonic dystrophy type 1 (DM1) were found to have different
-
PPMD 2024: Gene therapy trials recruiting patients around the world
With the first gene therapy for Duchenne muscular dystrophy (DMD) now approved in the U.S.
